Clinical Trial Update: A Post-authorization Study to Describe the Safety and Efficacy of Emapalumab for the Treatment of pHLH in Treatment Experienced Chinese Patients [Phase 4]

View source ↗

Summary

Phase 4 post-authorization study evaluating the safety and efficacy of emapalumab in treatment-experienced Chinese patients with primary hemophagocytic lymphohi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophagocytic Lymphohistiocytosis

Drugs mentioned

• Emapalumab (emapalumab)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Primary Hemophagocytic Lymphohistiocytosis | Phase 4 | Status: COMPLETED | Results posted: 2026-03-13